North Star Investment Management Corp. Cybin Inc. Transaction History

North Star Investment Management Corp.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 06, 2023	BUY	$0.29 - $0.63 $15,079 - $32,760	52,000 New	52,000 $27,000
Q1 2022 May 03, 2022	BUY	$0.74 - $1.22 $7,696 - $12,688	10,400 New	10,400 $8,000
Q4 2021 Feb 07, 2022	SELL	$1.13 - $2.31 $4,237 - $8,662	-3,750 Closed	0 $0
Q3 2021 Oct 20, 2021	BUY	$1.83 - $3.18 $6,862 - $11,925	3,750 New	3,750 $8,000

66.1K

Ticker CYBN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 166,120,000
Market Cap $1.65B
Description
Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to t...

Get notified when there are updates to the investment portfolio of North Star Investment Management Corp., based on Form 13F filings with the SEC.

Stay updated on North Star Investment Management Corp. with notifications on news.